SVS Guidelines Bundle

Peripheral Arterial Disease

SVS GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1309714

Contents of this Issue

Navigation

Page 7 of 11

Treatment 8 Table 6. General Considerations on Invasive Treatment for Intermittent Claudication Recommendations Grade Level of Evidence The SVS recommends endovascular therapy (EVT) or surgical treatment of IC for patients with significant functional or lifestyle-limiting disability when there is a reasonable likelihood of symptomatic improvement with treatment, when pharmacologic or exercise therapy, or both, have failed, and when the benefits of treatment outweigh the potential risks. 1 B The SVS recommends an individualized approach to select an invasive treatment for IC. The modality offered should provide a reasonable likelihood of sustained benefit to the patient (>50% likelihood of clinical efficacy for ≥2 years). For revascularization, anatomic patency (freedom from hemodynamically significant restenosis) is considered a prerequisite for sustained efficacy. 1 C Table 7. Interventions for Aortoiliac Occlusive Disease (AIOD) in Intermittent Claudication Recommendations Grade Level of Evidence The SVS recommends endovascular procedures over open surgery for focal AIOD causing IC. 1 B The SVS recommends endovascular interventions as first-line revascularization therapy for most patients with common iliac artery or external iliac artery occlusive disease causing IC. 1 B The SVS recommends the selective use of BMS or covered stents for aortoiliac angioplasty for common iliac artery or external iliac artery occlusive disease, or both, due to improved technical success and patency. 1 B The SVS recommends the use of covered stents for treatment of AIOD in the presence of severe calcification or aneurysmal changes where the risk of rupture may be increased after unprotected dilation. 1 C For patients with diffuse AIOD (eg, extensive aortic disease, disease involving both common and external iliac arteries) undergoing revascularization, the SVS suggests either endovascular or surgical intervention as first-line approaches. Endovascular interventions that may impair the potential for subsequent aortofemoral bypass in surgical candidates should be avoided. 2 B

Articles in this issue

Archives of this issue

view archives of SVS Guidelines Bundle - Peripheral Arterial Disease